Prestige Consumer Healthcare (PBH) Asset Utilization Ratio (2011 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Asset Utilization Ratio of 0.32 for Q4 2025, down 5.44% year-over-year from 0.34 in Q4 2024, and down 1.52% quarter-over-quarter from 0.32 in Q3 2025.
Prestige Consumer Healthcare (PBH) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.32 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio fell 5.44% year-over-year to 0.32; the TTM figure through Dec 2025 stood at 0.32 (down 5.44% YoY), while the FY2025 annual figure was 0.34, changed 0.37% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 0.32, down from 0.32 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.34 in Q4 2023, with the low at 0.27 in Q1 2021.
- The 5-year median for Asset Utilization Ratio is 0.32 (2025), against an average of 0.32.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio grew 13.88% in 2023, then declined 5.44% in 2025.
- Prestige Consumer Healthcare's Asset Utilization Ratio stood at 0.29 in 2021, then climbed by 3.52% to 0.3 in 2022, then grew by 13.88% to 0.34 in 2023, then slipped by 1.02% to 0.34 in 2024, then declined by 5.44% to 0.32 in 2025.
- Business Quant data shows PBH's Asset Utilization Ratio at 0.32 in Q4 2025, 0.32 in Q3 2025, and 0.33 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.32 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.34 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.34 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.34 |
| Dec 31, 2023 | 0.34 |
| Sep 30, 2023 | 0.34 |
| Jun 30, 2023 | 0.34 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.30 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.28 |
| Jun 30, 2021 | 0.28 |
| Mar 31, 2021 | 0.27 |